Patients are in an ideal position to identify the impact of medicines they have taken, particularly
on their quality of life. Systems for patients/consumer reporting are an important tool to
facilitate and encourage ‘spontaneous reporting’, which in turn contributes to the overall
knowledge of the safety of a medicine and the patient experience. The patients’ role in reporting
adverse drug reactions is a key element in building an improved system of pharmacovigilance
which monitors the benefit and risk profiles of our pharmaceutical products.
Pharmacovigilance helps determine the best conditions of use for treatments, and provides
physicians, healthcare professionals and patients with comprehensive, up-to-date safety
information, including potential risks associated with a product.
You may report any drug-related problem concerning EIPICo's medicinal products through:
- Electronically please click the link below :
- Email: Pharmacovigilance@eipico.net
- Landline No.: (+2) 0224143660 - 0224143550 Ext: 505 - 509
- Fax No.: (+2) 0224174528 – 0224143800
- Mobile No.: (+2) 01005870200 / (+2) 01023222791
For reporting drug-related Problems in the Kingdom of Saudi Arabia through
Egyptian International Pharmaceutical Industries Co. (EIPICO)
Pharmacovigilance Department
Address: 3046 Al Imam Faisal Ibn Turki Ibn Abdullah Khaldia Towers, Al Futah District Building No. 4, Floor No. 22, Office No. 42201 Riyadh 12632 – 7742, Saudi Arabia
Tel.: +966-11-4056428 # 121/115/116
Fax: +966-11-4123969
Request Medical Resources
If you have a general question about EIPICO medicines
Click here